» Articles » PMID: 22219191

Induction of COX-2 Enzyme and Down-regulation of COX-1 Expression by Lipopolysaccharide (LPS) Control Prostaglandin E2 Production in Astrocytes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2012 Jan 6
PMID 22219191
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Pathological conditions and pro-inflammatory stimuli in the brain induce cyclooxygenase-2 (COX-2), a key enzyme in arachidonic acid metabolism mediating the production of prostanoids that, among other actions, have strong vasoactive properties. Although low basal cerebral COX-2 expression has been reported, COX-2 is strongly induced by pro-inflammatory challenges, whereas COX-1 is constitutively expressed. However, the contribution of these enzymes in prostanoid formation varies depending on the stimuli and cell type. Astrocyte feet surround cerebral microvessels and release molecules that can trigger vascular responses. Here, we investigate the regulation of COX-2 induction and its role in prostanoid generation after a pro-inflammatory challenge with the bacterial lipopolysaccharide (LPS) in astroglia. Intracerebral administration of LPS in rodents induced strong COX-2 expression mainly in astroglia and microglia, whereas COX-1 expression was predominant in microglia and did not increase. In cultured astrocytes, LPS strongly induced COX-2 and microsomal prostaglandin-E(2) (PGE(2)) synthase-1, mediated by the MyD88-dependent NFκB pathway and influenced by mitogen-activated protein kinase pathways. Studies in COX-deficient cells and using COX inhibitors demonstrated that COX-2 mediated the high production of PGE(2) and, to a lesser extent, other prostanoids after LPS. In contrast, LPS down-regulated COX-1 in an MyD88-dependent fashion, and COX-1 deficiency increased PGE(2) production after LPS. The results show that astrocytes respond to LPS by a COX-2-dependent production of prostanoids, mainly vasoactive PGE(2), and suggest that the coordinated down-regulation of COX-1 facilitates PGE(2) production after TLR-4 activation. These effects might induce cerebral blood flow responses to brain inflammation.

Citing Articles

Colitis can reduce the cingulate cortex neuronal density in rats.

Amlashi F, Besharat S, Jahanshahi M, Shirzad-Aski H, Torshizi F BMC Gastroenterol. 2025; 25(1):171.

PMID: 40082771 PMC: 11907912. DOI: 10.1186/s12876-025-03745-x.


An artesunate-modified half-sandwich iridium(iii) complex inhibits colon cancer cell proliferation and metastasis through the STAT3 pathway.

Deng D, Xu N, Wang M, Zhang G, Su Y, Fang H RSC Chem Biol. 2024; 6(2):218-226.

PMID: 39697768 PMC: 11651070. DOI: 10.1039/d4cb00114a.


Anti-inflammatory effects of thymol: an emphasis on the molecular interactions through approach and molecular dynamic simulations.

Islam M, Bappi M, Bhuia M, Ansari S, Ansari I, Shill M Front Chem. 2024; 12:1376783.

PMID: 38983677 PMC: 11231963. DOI: 10.3389/fchem.2024.1376783.


Barbaloin Protects Pentylenetetrazol-Induced Cognitive Deficits in Rodents via Modulation of Neurotransmitters and Inhibition of Oxidative-Free-Radicals-Led Inflammation.

Altyar A, Afzal M, Ghaboura N, Alharbi K, Alenezi S, Sayyed N Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931365 PMC: 11206990. DOI: 10.3390/ph17060699.


Platelet-rich plasma attenuates the UPEC-induced cystitis via inhibiting MMP-2,9 activities and downregulation of NGF and VEGF in Canis Lupus Familiaris model.

Abdelgalil A, Yassin A, Khattab M, Abdelnaby E, Marouf S, Farghali H Sci Rep. 2024; 14(1):13612.

PMID: 38871929 PMC: 11176177. DOI: 10.1038/s41598-024-63760-y.


References
1.
Araki E, Forster C, Dubinsky J, Ross M, Iadecola C . Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity. Stroke. 2001; 32(10):2370-5. DOI: 10.1161/hs1001.096057. View

2.
Aid S, Silva A, Candelario-Jalil E, Choi S, Rosenberg G, Bosetti F . Cyclooxygenase-1 and -2 differentially modulate lipopolysaccharide-induced blood-brain barrier disruption through matrix metalloproteinase activity. J Cereb Blood Flow Metab. 2009; 30(2):370-80. PMC: 2818570. DOI: 10.1038/jcbfm.2009.223. View

3.
Gorina R, Santalucia T, Petegnief V, Ejarque-Ortiz A, Saura J, Planas A . Astrocytes are very sensitive to develop innate immune responses to lipid-carried short interfering RNA. Glia. 2008; 57(1):93-107. DOI: 10.1002/glia.20738. View

4.
Choi S, Langenbach R, Bosetti F . Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J. 2007; 22(5):1491-501. PMC: 2386977. DOI: 10.1096/fj.07-9411com. View

5.
Loftin C, Trivedi D, Tiano H, Clark J, Lee C, Epstein J . Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci U S A. 2001; 98(3):1059-64. PMC: 14708. DOI: 10.1073/pnas.98.3.1059. View